Dr. Philip Kantoff is the Chairman of Medicine at Memorial Sloan Kettering Cancer Center and Professor of Medicine at the Weill Cornell Medical College. He is also the incumbent George J. Bosl Chair in Medicine. Dr. Kantoff oversees the clinical care, translational and clinical research of almost 400 faculty members in the Department of Medicine. He ensures the mentorship of fellows and junior faculty and cares for patients with prostate cancer. Dr. Kantoff’s laboratory-based research is devoted principally to the genetics and genetic epidemiology of prostate cancer, resistance to androgen deprivation therapy and the discovery of new biomarkers as potential prognostic and therapeutic targets. He lectures widely on both his research and the care of patients with these malignancies.
Prior to his position at Memorial Sloan Kettering, Dr. Kantoff served in multiple capacities at the Dana-Farber Cancer Institute and Harvard Medical School for over 28 years. He was Professor of Medicine at Harvard Medical School and the first incumbent of the Jerome and Nancy Kohlberg Chair in Medicine. His roles included the Director of the Lank Center for Genitourinary Oncology where he supervised the clinical care, and the clinical and fundamental research within this Disease Center, which is devoted to genitourinary malignancies. He also served as leader of the Prostate Cancer Program at the Dana-Farber/Harvard Cancer Center, and PI of the Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE. He served as Vice Chair, Department of Medical Oncology and Chief, Division of the Solid Tumor Oncology, responsible for fostering the research in all of the Solid Tumor Disease Centers and ensuring the career development of its approximately 80 faculty members. Finally, he served as Chair, Executive Committee for Clinical Research.